| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Prelude Therapeutics Incorporated (PRLD) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. PRLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 11.81M | $51.01M | - | |
| 10% | 6.48M | $27.98M | - | |
| 10% | 1.13M | $4.86M | - | |
| Dir | 121.3K | $524.0K | - | |
| Pres | 86.9K | $375.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2021 | Scherle Peggy88 | Chief Scientific Officer | Sale+OE | 2,286 | $35.07 | $80,161.33 | -1.3% | -47.9% | -73.0% | |
| Aug 5, 2021 | Mauro David J90 | Chief Medical Officer | Sale+OE | 15,000 | $31.09 | $466,394.22 | -48.7% | -43.0% | -81.0% | |
| Jul 27, 2021 | Scherle Peggy88 | Chief Scientific Officer | Sale+OE | 20,000 | $35.47 | $709,379.88 | -5.5% | -49.1% | -83.0% | |
| Jul 6, 2021 | Mauro David J90 | Chief Medical Officer | Sale+OE | 15,000 | $27.47 | $412,107.04 | -75.5% | +17.1% | -79.6% | |
| Jun 7, 2021 | Mauro David J90 | Chief Medical Officer | Sale+OE | 15,000 | $32.44 | $486,622.35 | -36.3% | +16.8% | -85.2% | |
| May 25, 2021 | Piper Brian | Chief Financial Officer | Sale+OE | 8,333 | $34.27 | $285,537.22 | -51.8% | +0.8% | -86.6% | |
| May 7, 2021 | Scherle Peggy88 | Chief Scientific Officer | Sale+OE | 10,000 | $40.82 | $408,192.28 | -1.9% | -22.1% | -89.7% | |
| May 5, 2021 | Mauro David J90 | Chief Medical Officer | Sale+OE | 15,000 | $40.14 | $602,091.90 | -54.2% | -21.0% | -89.4% | |
| Apr 29, 2021 | Pierce Christopher82 | EVP And Chief Of Business Oper | Sale+OE | 3,295 | $40.29 | $132,764.78 | -46.8% | -14.0% | -88.7% | |
| Apr 29, 2021 | Morosini Deborah82 | EVP, Chief Of Clinical Affairs | Sale+OE | 3,223 | $40.29 | $129,853.38 | -87.9% | -14.0% | -88.7% |